Commentary on Nolan et al. (2014): Opiate substitution treatment and hepatitis C virus prevention: building an evidence base?
about
Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIVScaling up HCV prevention and treatment interventions in rural USA - model projections for tackling an increasing epidemic.Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: is elimination possible in a high-prevalence setting?Importance and Contribution of Community, Social, and Healthcare Risk Factors for Hepatitis C Infection in Pakistan.HCV elimination among people who inject drugs. Modelling pre- and post-WHO elimination era
P2860
Commentary on Nolan et al. (2014): Opiate substitution treatment and hepatitis C virus prevention: building an evidence base?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Commentary on Nolan et al. (20 ...... on: building an evidence base?
@ast
Commentary on Nolan et al. (20 ...... on: building an evidence base?
@en
type
label
Commentary on Nolan et al. (20 ...... on: building an evidence base?
@ast
Commentary on Nolan et al. (20 ...... on: building an evidence base?
@en
prefLabel
Commentary on Nolan et al. (20 ...... on: building an evidence base?
@ast
Commentary on Nolan et al. (20 ...... on: building an evidence base?
@en
P2860
P50
P356
P1433
P1476
Commentary on Nolan et al. (20 ...... on: building an evidence base?
@en
P2093
Lisa Maher
Matthew Hickman
P2860
P304
P356
10.1111/ADD.12750
P407
P577
2014-12-01T00:00:00Z